Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

4.69
Delayed Data
As of Aug 26
 +0.31 / +7.08%
Today’s Change
2.50
Today|||52-Week Range
7.72
-17.28%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2015
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization36.0K60.0K38.0K41.0K
 
 
 
 
 
 
Operating ExpensesGross Income-36.0K-60.0K-38.0K-41.0K
 
 
 
 
 
General Expenses23.1M26.9M27.5M36.8M
 
 
 
 
 
Research And Development20.4M19.9M21.2M26.6M
 
 
 
 
 
Total Operating Expenses23.2M26.9M27.6M36.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-23.2M-26.9M-27.6M-36.9M
 
 
 
 
 
Extraordinary Credit1.4M0.00260.0K0.00
 
 
 
Extraordinary Charge---30.0K-25.6M-23.0K
 
 
 
 
Interest Expense On Debt4.3M3.5M7.0M1.7M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-26.0M-30.4M-59.9M-38.6M
 
 
 
 
 
Net Income-26.0M-30.4M-59.9M-38.6M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS111.3M113.7M117.6M168.1M
 
 
 
 
 
Shares To Calculate EPS Diluted111.3M113.7M117.6M168.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.23-$0.27-$0.51-$0.23
 
 
 
 
 
EPS Diluted-$0.23-$0.27-$0.51-$0.23